No Data
No Data
Citius Oncology To Explore Strategic Alternatives, Engages Jefferies As Exclusive Financial Advisor
Express News | Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives
Citius Pharmaceuticals Upgraded to Buy From Hold at D. Boral Capital
D. Boral Capital Upgrades Citius Pharmaceuticals(CTXR.US) to Buy Rating, Announces Target Price $9
This American Airlines Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday
D. Boral Capital Upgrades Citius Pharma to Buy, Announces $9 Price Target